|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | OHSU Knight Cancer Institute |
|---|---|
| Collaborator: |
National Cancer Institute (NCI) |
| Information provided by (Responsible Party): | OHSU Knight Cancer Institute |
| ClinicalTrials.gov Identifier: | NCT00899522 |
Purpose
RATIONALE: Collecting and storing samples of tumor tissue from patients with Fanconi anemia to test in the laboratory may help the study of cancer in the future.
PURPOSE: This laboratory study is collecting and storing tumor tissue samples from patients with Fanconi anemia.
| Condition | Intervention |
|---|---|
|
Fanconi Anemia Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific |
Other: biologic sample preservation procedure Procedure: biopsy |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Retrospective |
| Official Title: | Fanconi Anemia Cancer Cell Repository |
| Estimated Enrollment: | 120 |
| Study Start Date: | August 2005 |
OBJECTIVES:
OUTLINE: Tumor biopsies are collected from patients with Fanconi anemia and archived for future molecular studies, cell line generation, and general usage by the research community at large. Medical information about the patient's cancer is also archived.
PROJECTED ACCRUAL: Not specified.
Eligibility| Ages Eligible for Study: | 1 Year to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
To recruit participants into this project, an announcement will be posted on the Fanconi Anemia Research Fund website (http://www.fanconi.org/) after IRB approval is obtained.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, Oregon | |
| Knight Cancer Institute at Oregon Health and Science University | Recruiting |
| Portland, Oregon, United States, 97239-3098 | |
| Contact: Clinical Trials Office - Knight Cancer Institute at Oregon Hea 503-494-1080 trials@ohsu.edu | |
| Principal Investigator: | Grover C. Bagby, MD | OHSU Knight Cancer Institute |
More Information
| Responsible Party: | OHSU Knight Cancer Institute |
| ClinicalTrials.gov Identifier: | NCT00899522 History of Changes |
| Other Study ID Numbers: | CDR0000445453, P30CA069533, OHSU-HEM-03022-LX, OHSU-IRB00001100, OSHU-CR00003822 |
| Study First Received: | May 9, 2009 |
| Last Updated: | September 6, 2011 |
| Health Authority: | United States: Federal Government |
|
Fanconi anemia unspecified adult solid tumor, protocol specific unspecified childhood solid tumor, protocol specific |
|
Anemia Fanconi Anemia Fanconi Syndrome Neoplasms Hematologic Diseases Anemia, Hypoplastic, Congenital Anemia, Aplastic Bone Marrow Diseases |
Genetic Diseases, Inborn DNA Repair-Deficiency Disorders Metabolic Diseases Kidney Diseases Urologic Diseases Renal Tubular Transport, Inborn Errors Metabolism, Inborn Errors |